中文     English
Ningbo David Medical Device Co., Ltd. (300314) will acquire 15.78% equity of Shenzheng Yanghe Bio-Tech Company with 30 millionRMB (US $5million) and 13.04% equity of Wuxi Xirui Technology Company

 

 

 

Ningbo David Medical Device Co., Ltd. (300314) intends to sign a capital increase agreement with Guangzhou Improve Medical Instruments Co., Ltd. (300030), Zhuhai Hokai Medical Instruments Co., Ltd. (300273), Blue Sail Medical Co., Ltd. (002382) to invest in Shenzheng Yanghe Bio-Tech Company. Ningbo David Medical Device intends to acquire 15.7895% registered capital of Shenzheng Yanghe Bio-Tech Company with 30,000,000 RMB (US $5 million). To achieve its strategic objectives and further its business plans, Ningbo David Medical Device intends to acquire 13.04% equity of Wuxi Xirui Technology Company with 45,000,000 RMB (US $7.5 million), which focuses on upstream stem cell storage industry. Currently, Wuxi Xirui Technology Company has developed stem cell storage for newborns.

 

For more information, please contact us at jun.yuan@bfcgroup.biz